Physician profile
Whitney M Dellinger
NPI 1487154894
$973.17
in general payments reported to CMS, 2019-2025
18 companies · $18.00 in 2025
The $18.00 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $439 · 2022: $101 · 2023: $368 · 2024: $47.16 · 2025: $18.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $210.15 | 2021-2023 | |
| Esperion Therapeutics, INC. | $195.12 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $111.74 | 2021-2023 | Farxiga |
| Abbott Laboratories | $105.01 | 2023-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $69.10 | 2022-2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $51.32 | 2021-2023 | Trintellix |
| Lilly USA, LLC | $42.89 | 2022-2023 | Mounjaro |
| Exact Sciences Corporation | $32.80 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $29.95 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.25 | 2021 | |
| Novo Nordisk INC | $15.84 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.42 | 2021 | |
| Pfizer INC. | $14.58 | 2022 | |
| Astellas Pharma US INC | $14.29 | 2021 | |
| Edwards Lifesciences Corporation | $12.53 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.43 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.32 | 2021 | |
| Merck Sharp & Dohme LLC | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Dellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.